VanEck Associates
SBRA icon

VanEck Associates’s Sabra Healthcare REIT SBRA Stock Holding History

VanEck Associates’s Portfolio SBRA Stock Details SBRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.55M Sell
130,550
-525
-0.4% -$10.4K ﹤0.01% 994
2026
Q1 		$2.52M Buy
131,075
+67,514
+106% +$1.33M ﹤0.01% 945
2025
Q4 		$1.2M Buy
63,561
+5,689
+10% +$105K ﹤0.01% 1055
2025
Q3 		$1.08M Buy
57,872
+5,649
+11% +$106K ﹤0.01% 1074
2025
Q2 		$963K Buy
52,223
+5,557
+12% +$98.6K ﹤0.01% 1063
2025
Q1 		$815K Buy
46,666
+1,869
+4% +$31.5K ﹤0.01% 1078
2024
Q4 		$776K Buy
44,797
+5,025
+13% +$91.8K ﹤0.01% 1071
2024
Q3 		$755K Buy
39,772
+4,366
+12% +$73.6K ﹤0.01% 1033
2024
Q2 		$545K Buy
35,406
+2,201
+7% +$31.4K ﹤0.01% 1064
2024
Q1 		$490K Buy
33,205
+759
+2% +$10.5K ﹤0.01% 1069
2023
Q4 		$463K Buy
32,446
+5,335
+20% +$75.8K ﹤0.01% 1059
2023
Q3 		$378K Buy
27,111
+1,124
+4% +$14.4K ﹤0.01% 1076
2023
Q2 		$306K Buy
25,987
+744
+3% +$8.47K ﹤0.01% 1121
2023
Q1 		$290K Buy
25,243
+1,308
+5% +$16.2K ﹤0.01% 1112
2022
Q4 		$298K Buy
23,935
+10,630
+80% +$136K ﹤0.01% 1012
2022
Q3 		$175K Sell
13,305
-7,632
-36% -$113K ﹤0.01% 1053
2022
Q2 		$292K Buy
20,937
+482
+2% +$6.44K ﹤0.01% 1000
2022
Q1 		$305K Buy
20,455
+2,679
+15% +$36.7K ﹤0.01% 1026
2021
Q4 		$241K Buy
17,776
+7,492
+73% +$106K ﹤0.01% 1071
2021
Q3 		$151K Buy
10,284
+1,586
+18% +$26.8K ﹤0.01% 1071
2021
Q2 		$158K Buy
8,698
+153
+2% +$2.72K ﹤0.01% 1033
2021
Q1 		$148K Buy
8,545
+292
+4% +$5.13K ﹤0.01% 971
2020
Q4 		$143K Buy
8,253
+2,057
+33% +$32.8K ﹤0.01% 878
2020
Q3 		$85K Buy
6,196
+1,177
+23% +$17.3K ﹤0.01% 900
2020
Q2 		$72K Buy
5,019
+2,551
+103% +$33.5K ﹤0.01% 883
2020
Q1 		$27K Buy
2,468
+1,336
+118% +$24.6K ﹤0.01% 908
2019
Q4 		$24K Buy
+1,132
New +$25.3K ﹤0.01% 906

Other funds holding SBRA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CIM
Centersquare Investment Management Conshohocken, Pennsylvania $11.7B AUM 20.39% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

VanEck Associates's SBRA Position: Q2 2026 in Review

VanEck Associates reduced its Sabra Healthcare REIT (SBRA) stake by 0.4% in Q2 2026, selling an estimated $10.4K and leaving 130,550 shares worth $2.55M. The position accounts for ﹤0.01% of the portfolio, ranked #994.

VanEck Associates first reported a position in SBRA in Q4 2019 and has held it in 27 quarters since. 464 funds tracked by Wall St. Rank hold SBRA as of Q2 2026.

  • VanEck Associates held 130,550 shares of Sabra Healthcare REIT worth $2.55M as of Q2 2026.
  • VanEck Associates sold 525 Sabra Healthcare REIT shares in Q2 2026, an estimated $10.4K.
  • Sabra Healthcare REIT made up ﹤0.01% of VanEck Associates's portfolio in Q2 2026, its #994 holding.
  • VanEck Associates first reported a position in Sabra Healthcare REIT in Q4 2019 and has held it in 27 quarters since.
  • 464 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q2 2026.

Based on VanEck Associates's 13F filing for Q2 2026, filed 14 Aug 2026.